Reduced ability to neutralize the Omicron variant among adults after infection and complete vaccination with BNT162b2, ChAdOx1, or CoronaVac and heterologous boosting

COVID-19 vaccines have dramatically reduced rates of severe infection requiring hospitalization. However, SARS-CoV-2 variants have reduced vaccine effectiveness at preventing any symptomatic infection. This real-world study analyzed binding and neutralizing antibodies generated after complete vaccin...

Descripción completa

Detalles Bibliográficos
Autores principales: Espíndola, Otávio Melo, Fuller, Trevon L., de Araújo, Mia Ferreira, Tort, Luis Fernando Lopez, Guaraldo, Lusiele, Calvet, Guilherme, Resende, Paola, Bonaldo, Myrna, Whitworth, Jimmy, Smith, Chris, Siqueira, Marilda, Brasil, Patrícia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165291/
https://www.ncbi.nlm.nih.gov/pubmed/37156846
http://dx.doi.org/10.1038/s41598-023-34035-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165291/
https://www.ncbi.nlm.nih.gov/pubmed/37156846
http://dx.doi.org/10.1038/s41598-023-34035-9

Ejemplares similares